Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio de las Morenas

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Journal of Gastrointestinal Oncology|August 2, 2014
Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin DViola Zhu, Antonio de Las Morenas, Milos Janicek, et al.
Thyroid : Official Journal of the American Thyroid Association|February 18, 2011
In thyroid fine-needle aspiration, use of bedside-prepared slides significantly increased diagnostic adequacy and specimen cellularity relative to solution-based samplesTobin M Abraham, Antonio de las Morenas, Stephanie L Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2010
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epitheliumKelly Graham, Xijin Ge, Antonio de Las Morenas, et al.
Breast Cancer Research : BCR|March 8, 2011
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancerBethany N Hannafon, Paola Sebastiani, Antonio de las Morenas, et al.
Pathology Oncology Research : POR|January 16, 2015
Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targetsHao Wu, Yue Sun, Huihui Ye, et al.
The American Journal of Pathology|July 11, 2002
Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomasPamela S Larson, Antonio de las Morenas, Sheila R Bennett, et al.
American Journal of Obstetrics and Gynecology|March 13, 2010
Abnormal anal cytology in HIV-infected womenRicha Tandon, Amy S Baranoski, Faye Huang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2008
Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reactionJohn N Flanagan, Pedro Pineda, Philip E Knapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissuesPamela S Larson, Benjamin L Schlechter, Antonio de las Morenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrenceBenjamin L Schlechter, Qiong Yang, Pamela S Larson, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Journal of Gastrointestinal Oncology|August 2, 2014
Hypercalcemia from metastatic pancreatic neuroendocrine tumor secreting 1,25-dihydroxyvitamin DViola Zhu, Antonio de Las Morenas, Milos Janicek, et al.
Thyroid : Official Journal of the American Thyroid Association|February 18, 2011
In thyroid fine-needle aspiration, use of bedside-prepared slides significantly increased diagnostic adequacy and specimen cellularity relative to solution-based samplesTobin M Abraham, Antonio de las Morenas, Stephanie L Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2010
Gene expression profiles of estrogen receptor-positive and estrogen receptor-negative breast cancers are detectable in histologically normal breast epitheliumKelly Graham, Xijin Ge, Antonio de Las Morenas, et al.
Breast Cancer Research : BCR|March 8, 2011
Expression of microRNA and their gene targets are dysregulated in preinvasive breast cancerBethany N Hannafon, Paola Sebastiani, Antonio de las Morenas, et al.
Pathology Oncology Research : POR|January 16, 2015
Anaplastic thyroid cancer: outcome and the mutation/expression profiles of potential targetsHao Wu, Yue Sun, Huihui Ye, et al.
The American Journal of Pathology|July 11, 2002
Loss of heterozygosity or allele imbalance in histologically normal breast epithelium is distinct from loss of heterozygosity or allele imbalance in co-existing carcinomasPamela S Larson, Antonio de las Morenas, Sheila R Bennett, et al.
American Journal of Obstetrics and Gynecology|March 13, 2010
Abnormal anal cytology in HIV-infected womenRicha Tandon, Amy S Baranoski, Faye Huang, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|March 1, 2008
Expression of cytokeratin 19 in the diagnosis of thyroid papillary carcinoma by quantitative polymerase chain reactionJohn N Flanagan, Pedro Pineda, Philip E Knapp, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2005
Allele imbalance, or loss of heterozygosity, in normal breast epithelium of sporadic breast cancer cases and BRCA1 gene mutation carriers is increased compared with reduction mammoplasty tissuesPamela S Larson, Benjamin L Schlechter, Antonio de las Morenas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2004
Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrenceBenjamin L Schlechter, Qiong Yang, Pamela S Larson, et al.
Pageof 2